Insider trades
Fitzgerald Kevin Joseph, Director of Ovid Therapeutics OVID, has filed 0 purchases and 152 sales on the open market. Over the past 12 months that comes to a net sale of $10.7M. The latest trade was on 04/07.
Fitzgerald Kevin Joseph
Director
- Company
- Ovid Therapeutics OVID
- First filing
- 23/02/27
- Trades
- 178 trades
- Buys / sales
- 0 / 152
- 12-month net buying
- −$10.7M
- Last trade
- 04/07
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
ALNY | Open-market sale10b5-1 plan | 03/04–03/05 | 03/06 | 1,291 sh12 trades | $323.54avg. | $417,685.48 | −5.9% |
ALNY | Open-market sale10b5-1 plan | 03/02–03/03 | 03/04 | 3,250 sh14 trades | $323.62avg. | $1,051,773.01 | −12.9% |
ALNY | Open-market sale10b5-1 plan | 02/13–02/17 | 02/17 | 4,000 sh2 trades | $321.24avg. | $1,284,977.08 | −15.8% |
ALNY | Open-market sale10b5-1 plan | 01/12–01/13 | 01/14 | 3,800 sh27 trades | $367.37avg. | $1,395,992 | −15.2% |
ALNY | Open-market sale10b5-1 plan | 25/11/17 | 25/11/19 | 12,128 sh11 trades | $452.18avg. | $5,483,989.61 | −36.3% |
ALNY | Open-market sale | 25/10/02 | 25/10/03 | 2,441 sh12 trades | $452.05avg. | $1,103,451.46 | −8.8% |
ALNY | Open-market sale | 25/08/18 | 25/08/19 | 1,396 sh8 trades | $453.27avg. | $632,758.71 | −5.8% |
ALNY | Open-market sale10b5-1 plan | 25/03/03–25/03/04 | 25/03/05 | 2,755 sh14 trades | $242.94avg. | $669,304.07 | −16.9% |
ALNY | Open-market sale | 25/02/28 | 25/03/03 | 496 sh8 trades | $241.69avg. | $119,877.91 | −3.9% |
ALNY | Open-market sale10b5-1 plan | 25/02/14–25/02/18 | 25/02/18 | 2,103 sh17 trades | $252.71avg. | $531,447.79 | −14.0% |
ALNY | Open-market sale10b5-1 plan | 24/11/26–24/11/27 | 24/11/27 | 3,000 sh9 trades | $251.65avg. | $754,946.54 | −18.9% |
ALNY | Open-market sale10b5-1 plan | 24/08/12 | 24/08/14 | 22,025 sh6 trades | $270.99avg. | $5,968,515.6 | −63.1% |
ALNY | Open-market sale | 24/06/25 | 24/06/26 | 1,198 sh12 trades | $230.99avg. | $276,730.75 | −7.8% |
